Organization · Venture Capital
MediVentures GmbH
MediVentures GmbH is a venture capital firm based in Iserlohn, Germany, focusing on life sciences and digital health investments. It operates as the venture capital arm of the Puetter family office, emphasizing fund-of-funds and co-investment strategies.
Overview
What MediVentures GmbH does
What MediVentures GmbH is
MediVentures GmbH is a venture capital firm based in Iserlohn, Germany, focusing on life sciences and digital health investments. It operates as the venture capital arm of the Puetter family office, emphasizing fund-of-funds and co-investment strategies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 28, 2026
Official channels
Find MediVentures GmbH elsewhere
Open the official website or a supported primary organization account.
Capability profile
MediVentures GmbH as a funder
Investment thesis
MediVentures promotes future-proof technologies in a sustainable healthcare system, seeking LP positions in VC funds with opportunities for co-investments, particularly in health-related sectors.
Focus narrative
MediVentures invests in sectors including digital health, nutrition, clean and reliable energy, environmental and climate technology, agricultural technology, and space. The organization is particularly interested in funds that are active in pre-seed, Series A, and Series B stages, primarily within the EU, EFTA, and UK, while also considering select investments in US and Israeli companies.
Value beyond capital
MediVentures provides strategic capital and access to a robust German healthcare network, supporting portfolio companies with resources and connections that enhance healthcare delivery, diagnostics, and patient engagement.
Terms and economics
- Typical check
- $5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Series B
- Regions
- Eu · Uk · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
MediVentures has invested in several notable companies, including: Actitrexx GmbH: Develops cellular therapy Actileucel to prevent Graft-versus-Host Disease (GvHD) in stem cell transplantation. Anvajo GmbH: Creates innovative solutions for liquid analysis with a compact platform called 'fluidlab.' XO Life GmbH: Focuses on making digital healthcare accessible and valuable. Brainjo GmbH: Offers virtual reality solutions for burnout prevention in corporate health management. Keleya Digital-Health Solutions GmbH: Supports expectant mothers with digital access to information and services during pregnancy.
Common questions
What to know about MediVentures GmbH
Upseed classifies MediVentures GmbH under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.